Release of noradrenaline from the dog heart in situ after intravenous and intracoronary administration of 5-hydroxytryptamine.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002852:Chromatography, Ion Exchange; D003331:Coronary Vessels; D004285:Dogs; D005260:Female; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009411:Nerve Endings / Q000378:metabolism; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism*; D012701:Serotonin / Q000494:pharmacology*; D013053:Spectrophotometry; D014316:Tritium
D000319:Adrenergic beta-Antagonists; D014316:Tritium; D012701:Serotonin; D009638:Norepinephrine